COVID-19 Treatments: Efficacy and safety of ch loroquine or hydroxych loroquine in moderate type of COVID-19: a prospective open-label randomized controlled study

@CovidAnalysis

HC Q study #52
See all studies

6/22

Positive

Early treatment study

Chen et al., medRxiv, doi:10.1101/2020.06.19.20136093 (Preprint)

Efficacy and safety of ch loroquine or hydroxych loroquine in moderate type of COVID-19: a prospective open-label randomized controlled study

Significantly faster clinical recovery and shorter time to RNA negative (from 7.0 days to 2.0 days (HC Q), p=0.01. 67 patients with mild/moderate cases.

Source

See all studies

Please send us corrections, updates, or comments.

Submit